These outcomes summarize more than 5 years of experience administering intravenous vancomycin (4 mg/mL) safely and cost-efficiently through a nontrimmable midline catheter” Caparas and Hung (2017).
Abstract:
Background: The 2016 Infusion Therapy Standards of Practice no longer require that low pH (<5) medications be administered via central venous access devices. Nevertheless, the practice of placing PICCs for vancomycin administration often persists.
[ctt link=”y2ftw” template=”1″]ReTweet if useful… 5 years experience administering intravenous vancomycin through a midline catheter https://ctt.ec/y2ftw+ @ivteam #ivteam[/ctt]
Purpose: To demonstrate the safety and efficacy of intravenous vancomycin administration through a short and long term midline catheter.
Methodology: A retrospective chart review was performed on 1086 patients who received intravenous vancomycin through a midline catheter.
Results: There were no catheter-associated bloodstream infections and no deep vein thromboses. Phlebitis occurred rarely (0.6%), as did benign infiltrations (1.2%). There were no extravasation injuries.
Conclusions: These outcomes summarize more than 5 years of experience administering intravenous vancomycin (4 mg/mL) safely and cost-efficiently through a nontrimmable midline catheter.
[button link=”http://www.avajournal.com/article/S1552-8855(16)30127-1/pdf” color=”default”]Full Text[/button]
[spacer height=”20px”]
Reference:
Caparas, J.V. and Hung, H-S. (2017) Vancomycin Administration Through a Novel Midline Catheter: Summary of a 5-Year, 1086-Patient Experience in an Urban Community Hospital. The Journal of the Association for Vascular Access. 22(1), p.38-41.
DOI: http://dx.doi.org/10.1016/j.java.2016.10.092
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]